Log in to save to my catalogue

Radiobioconjugate targeted therapy in cancer, using radiolabeled mediated biological analogs: Desire...

Radiobioconjugate targeted therapy in cancer, using radiolabeled mediated biological analogs: Desire...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fd2fb531f2184de7a4c55162e924ce16

Radiobioconjugate targeted therapy in cancer, using radiolabeled mediated biological analogs: Desired qualities and selective targeting approach

About this item

Full title

Radiobioconjugate targeted therapy in cancer, using radiolabeled mediated biological analogs: Desired qualities and selective targeting approach

Author / Creator

Publisher

Wolters Kluwer Medknow Publications

Journal title

Biomedical and biotechnology research journal, 2022-01, Vol.6 (1), p.40-49

Language

English

Formats

Publication information

Publisher

Wolters Kluwer Medknow Publications

More information

Scope and Contents

Contents

Radiobioconjugate therapy, recommended as one of the effective modalities for the treatment of cancer cells, is based on the concept of delivering the localized radiation at the cellular level to the disease site using a biological moiety. The high tumor/nontumor ratio is the essentially a sine qua non for the successful execution of targeted thera...

Alternative Titles

Full title

Radiobioconjugate targeted therapy in cancer, using radiolabeled mediated biological analogs: Desired qualities and selective targeting approach

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_fd2fb531f2184de7a4c55162e924ce16

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fd2fb531f2184de7a4c55162e924ce16

Other Identifiers

ISSN

2588-9834

E-ISSN

2588-9842

DOI

10.4103/bbrj.bbrj_282_21

How to access this item